ClinConnect ClinConnect Logo
Search / Trial NCT05751889

Serious Game Interventions to Reduce Viral Hepatitis C Among PLWH-MSM

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Feb 28, 2023

Trial Information

Current as of August 21, 2025

Recruiting

Keywords

Serious Game Viral Hepatitis C Sexually Transmitted Infections Health Belief Model Harm Reduction Sexualized Drugs Behavioral Interventions

ClinConnect Summary

This clinical trial is looking at ways to help men who have sex with men (MSM) and are living with HIV reduce their risk of getting viral hepatitis C (HCV). The study will provide participants with health education either through a fun and engaging video game or through traditional online learning. After the education sessions, participants will be monitored for 48 weeks to see if their risky sexual behaviors change and whether they acquire HCV or other sexually transmitted infections (STIs).

To be eligible for this study, participants should be high-risk MSM living with HIV, which means they might have had a previous hepatitis C infection, experienced other STIs in the last year, or had certain liver health issues. It’s important that they can use a mobile smartphone and understand the provided materials. Participants can expect to learn important health information and will be followed up for nearly a year to track any changes in their health behaviors. If you or someone you know fits this description and is interested, it could be a valuable opportunity to gain knowledge and support.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • * High-risk MSM living with HIV, defined as:
  • 1. Had prior HCV infection, and had cleared HCV through treatment or spontaneously
  • 2. Had any STI within the past 12 months
  • 3. Had any unexplained elevation of liver transaminase in the past 6 months
  • 4. Had at least 1 unprotected anal sex during the past 6 months
  • Being able to use mobile smartphone and understand study materials
  • Repeat entry of study is permitted, but the interval between health education intervention should \>52 weeks.
  • Exclusion Criteria:
  • HCV RNA positive and yet clear virus (nor reaching SVR12).
  • Admission for any acute illness (including AIDS-defining conditions)

About National Taiwan University Hospital

National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.

Locations

Taipei, , Taiwan

Patients applied

0 patients applied

Trial Officials

Chien-Ching Hung, PhD

Principal Investigator

National Taiwan University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials